首页> 美国卫生研究院文献>Arthritis Research >A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis
【2h】

A novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis

机译:一种测量基质金属蛋白酶在关节炎患者滑液中总净蛋白水解活性中贡献的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite decades of research, only a very limited number of matrix metalloproteinase (MMP) inhibitors have been successful in clinical trials of arthritis. One of the central problems associated with this failure may be our inability to monitor the local activity of proteases in the joints since the integrity of the extracellular matrix results from an equilibrium between noncovalent, 1:1 stoichiometric binding of protease inhibitors to the catalytic site of the activated forms of the enzymes. In the present work, we have measured by flow cytometry the net proteolytic activity in synovial fluids (SF) collected from 95 patients with osteoarthritis and various forms of inflammatory arthritis, including rheumatoid arthritis, spondyloarthropathies, and chronic juvenile arthritis. We found that SF of patients with inflammatory arthritis had significantly higher levels of proteolytic activity than those of osteoarthritis patients. Moreover, the overall activity in inflammatory arthritis patients correlated positively with the number of infiltrated leukocytes and the serum level of C-reactive protein. No such correlations were found in osteoarthritis patients. Members of the MMP family contributed significantly to the proteolytic activity found in SF. Small-molecular-weight MMP inhibitors were indeed effective for inhibiting proteolytic activity in SF, but their effectiveness varied greatly among patients. Interestingly, the contribution of MMPs decreased in patients with very high proteolytic activity, and this was due both to a molar excess of tissue inhibitor of MMP-1 and to an increased contribution of other proteolytic enzymes. These results emphasize the diversity of the MMPs involved in arthritis and, from a clinical perspective, suggest an interesting alternative for testing the potential of new protease inhibitors for the treatment of arthritis.
机译:尽管进行了数十年的研究,但在关节炎的临床试验中仅成功使用了非常有限数量的基质金属蛋白酶(MMP)抑制剂。与这种失败有关的主要问题之一可能是我们无法监测关节中蛋白酶的局部活性,因为胞外基质的完整性是由蛋白酶抑制剂与COS催化位点的非共价1:1化学计量结合之间的平衡所致。酶的活化形式。在目前的工作中,我们已经通过流式细胞仪测量了从95例骨关节炎和各种形式的炎症性关节炎(包括类风湿性关节炎,脊椎骨关节炎和慢性青少年关节炎)患者身上收集的滑液(SF)中的净蛋白水解活性。我们发现,炎性关节炎患者的SF蛋白水解活性水平明显高于骨关节炎患者。此外,炎性关节炎患者的总体活动与浸润的白细胞数量和血清C反应蛋白水平呈正相关。在骨关节炎患者中未发现此类相关性。 MMP家族的成员对SF中的蛋白水解活性做出了重要贡献。小分子MMP抑制剂确实可以有效抑制SF中的蛋白水解活性,但患者之间的效果差异很大。有趣的是,在具有非常高蛋白水解活性的患者中,MMP的贡献降低了,这是由于MMP-1组织抑制剂的摩尔过量和其他蛋白水解酶的贡献增加所致。这些结果强调了参与关节炎的MMP的多样性,并且从临床角度来看,为测试新型蛋白酶抑制剂治疗关节炎的潜力提出了一种有趣的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号